1. Potential of Pre-Operative Serum Interleukin-6 as a Biomarker for Colorectal Cancers
   W.M.M.S. Bandara et al, 2024, Journal of Cancer Research Updates CrossRef
2. IL10 as Cancer Biomarker
   Maria Teresa Gonzalez-Garza et al, 2021, Translational Research in Cancer CrossRef
3. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer
   Biao Zhang et al, 2023, Frontiers in Endocrinology CrossRef
4. Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer
   Xiaodong Feng et al, 2020, Disease Markers CrossRef
5. Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
   Agnieszka Szczygieł et al, 2023, Frontiers in Immunology CrossRef
6. Peritoneal and Systemic Interleukin-10 as Early Biomarkers for Colorectal Anastomotic Leakage Following Surgery in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
   Lucía Villegas-Coronado et al, 2023, Polish Journal of Surgery CrossRef
7. Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment
   Changpei Cheng et al, 2020, Frontiers in Pharmacology CrossRef